DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Candriam S.C.A.'s Holding History (CIK: 0001537014)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,166,379 Value ($000) $19,258 Avg Close $16.88 Range $13.75 - $20.61
Q3 2025
Shares 833,582 Value ($000) $12,104 Avg Close $14.37 Range $12.58 - $16.20
Q2 2025
Shares 844,249 Value ($000) $11,812 Avg Close $14.07 Range $10.57 - $16.97
Q1 2025
Shares 858,162 Value ($000) $11,667 Avg Close $19.16 Range $13.30 - $24.34
Q4 2024
Shares 832,977 Value ($000) $16,976 Avg Close $25.60 Range $19.93 - $33.33
Q3 2024
Shares 942,158 Value ($000) $27,444 Avg Close $24.79 Range $19.74 - $32.13
Q2 2024
Shares 726,499 Value ($000) $16,869 Avg Close $19.20 Range $14.56 - $23.87
Q1 2024
Shares 447,878 Value ($000) $9,190 Avg Close $18.79 Range $15.49 - $23.52
Q4 2023
Shares 357,878 Value ($000) $7,680 Avg Close $19.81 Range $15.45 - $23.81
Q3 2023
Shares 357,878 Value ($000) $7,383 Avg Close $25.37 Range $20.52 - $30.79
Q2 2023
Shares 357,878 Value ($000) $10,561 Avg Close $28.12 Range $22.72 - $33.31
Q1 2023
Shares 357,878 Value ($000) $7,589 Avg Close $27.52 Range $21.74 - $32.81
Q4 2022
Shares 357,878 Value ($000) $9,952 Avg Close $29.75 Range $25.96 - $34.78
Q3 2022
Shares 357,878 Value ($000) $10,984 Avg Close $32.51 Range $25.88 - $39.43
Q2 2022
Shares 322,882 Value ($000) $9,502 Avg Close $26.20 Range $20.24 - $35.62
Q1 2022
Shares 141,507 Value ($000) $4,552 Avg Close $34.41 Range $28.76 - $47.47
Q4 2021
Shares 141,507 Value ($000) $6,311 Avg Close $47.38 Range $41.10 - $56.08
Q3 2021
Shares 63,781 Value ($000) $3,218 Avg Close $56.36 Range $47.02 - $79.50
Q2 2021
Shares 63,781 Value ($000) $5,003 Avg Close $61.86 Range $49.20 - $79.70